ADGRL3 (LPHN3) variants predict substance use disorder

Mauricio (Oscar) Arcos-Burgos, Jorge Velez, Ariel F Martinez, Marta Ribasés, Josep A Ramos-Quiroga, Cristina Sánchez-Mora, V. Richarte, Carlos Roncero, Bru Cormand, Noelia Fernández-Castillo, M. Casas , Francisco Lopera, Brett Lidbury, Saul Newman, Simon Easteal, Hardip Patel

    Research output: Contribution to journalArticlepeer-review

    32 Citations (Scopus)

    Abstract

    Genetic factors are strongly implicated in the susceptibility to develop externalizing syndromes such as attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder, conduct disorder, and substance use disorder (SUD). Variants in the ADGRL3 (LPHN3) gene predispose to ADHD and predict ADHD severity, disruptive behaviors comorbidity, long-term outcome, and response to treatment
    Original languageEnglish
    Pages (from-to)15pp
    JournalTranslational Psychiatry
    Volume9
    Issue number42
    DOIs
    Publication statusPublished - 2019

    Fingerprint

    Dive into the research topics of 'ADGRL3 (LPHN3) variants predict substance use disorder'. Together they form a unique fingerprint.

    Cite this